Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AtriCure stock

Learn how to easily invest in AtriCure stock.

AtriCure Inc
NASDAQ: ATRC - USD
$40.51
- $0.35 ( - 0.86%)
MEDICAL INSTRUMENTS & SUPPLIES

AtriCure Inc is a medical instruments & supplies business based in the US. AtriCure shares (ATRC) are listed on the NASDAQ and all prices are listed in US Dollars. AtriCure employs 875 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in AtriCure

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ATRC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

AtriCure stock price (NASDAQ: ATRC)

Use our graph to track the performance of ATRC stocks over time.

AtriCure shares at a glance

Information last updated 2022-06-23.
Latest market close$40.86
52-week range$32.84 - $89.18
50-day moving average $46.30
200-day moving average $63.47
Wall St. target price$78.60
PE ratio 35.1515
Dividend yield $0 (0%)
Earnings per share (TTM) $1.12

Buy AtriCure shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AtriCure stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AtriCure price performance over time

Historical closes compared with the close of $40.86 from 2022-06-30

1 week (2022-06-24) -0.15%
1 month (2022-05-28) N/A
3 months (2022-04-01) -38.10%
6 months (2021-12-28) N/A
1 year (2021-07-01) -49.57%
2 years (2020-07-01) -9.74%
3 years (2019-07-01) 33.62%
5 years (2017-06-30) 68.49%

Is AtriCure stock undervalued or overvalued?

Valuing AtriCure stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AtriCure's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AtriCure's P/E ratio

AtriCure's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, AtriCure shares trade at around 35x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

AtriCure financials

Revenue TTM $289.6 million
Gross profit TTM $205.9 million
Return on assets TTM -4.68%
Return on equity TTM 12.16%
Profit margin 17.93%
Book value $10.00
Market capitalisation $1.8 billion

TTM: trailing 12 months

AtriCure share dividends

We're not expecting AtriCure to pay a dividend over the next 12 months.

AtriCure share price volatility

Over the last 12 months, AtriCure's shares have ranged in value from as little as $32.84 up to $89.18. A popular way to gauge a stock's volatility is its "beta".

ATRC.US volatility(beta: 1.21)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AtriCure's is 1.2114. This would suggest that AtriCure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

AtriCure overview

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Frequently asked questions

What percentage of AtriCure is owned by insiders or institutions?
Currently 2.812% of AtriCure shares are held by insiders and 99.668% by institutions.
How many people work for AtriCure?
Latest data suggests 875 work at AtriCure.
When does the fiscal year end for AtriCure?
AtriCure's fiscal year ends in December.
Where is AtriCure based?
AtriCure's address is: 7555 Innovation Way, Mason, OH, United States, 45040
What is AtriCure's ISIN number?
AtriCure's international securities identification number is: US04963C2098
What is AtriCure's CUSIP number?
AtriCure's Committee on Uniform Securities Identification Procedures number is: 04963C209

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site